
| ASSET | DATE | % RETURN |
|---|---|---|
Diversified Energy (DEC) | 11/29/2023 - 12/5/2023 | 1,821.5% |
FiEE (FIEE) | 11/29/2023 - 12/5/2023 | 334.18% |
Eyepoint Pharmaceuticals (EYPT) | 11/29/2023 - 12/5/2023 | 188.46% |
XBP Europe (XBP) | 11/29/2023 - 12/5/2023 | 172.94% |
Chanson International Holding Class A Ordinary Shares (CHSN) | 11/29/2023 - 12/5/2023 | 165.92% |
QXO (QXO) | 11/29/2023 - 12/5/2023 | 162.67% |
Sphere 3D (ANY) | 11/29/2023 - 12/5/2023 | 136.73% |
Mawson Infrastructure (MIGI) | 11/29/2023 - 12/5/2023 | 130% |
Incannex Healthcare Ltd ADR (IXHL) | 11/29/2023 - 12/5/2023 | 125% |
Alterity Therapeutics (ATHE) | 11/29/2023 - 12/5/2023 | 92.86% |
Skye Bioscience, Inc Common Stock (SKYE) | 11/29/2023 - 12/5/2023 | 82.05% |
Garden Stage Limited Ordinary Shares (GSIW) | 11/29/2023 - 12/5/2023 | 80.5% |
DarioHealth (DRIO) | 11/29/2023 - 12/5/2023 | 77.88% |
OneMedNet (ONMDW) | 11/29/2023 - 12/5/2023 | 71.43% |
Altimmune (ALT) | 11/29/2023 - 12/5/2023 | 66.24% |
DeFi Development (DFDV) | 11/29/2023 - 12/5/2023 | 63.67% |
Soligenix (SNGX) | 11/29/2023 - 12/5/2023 | 62.79% |
Mercurity Fintech Holding Inc ADR (MFH) | 11/29/2023 - 12/5/2023 | 62.53% |
BTCS (BTCS) | 11/29/2023 - 12/5/2023 | 60.79% |
Terns Pharmaceuticals (TERN) | 11/29/2023 - 12/5/2023 | 59.31% |
Biomea Fusion (BMEA) | 11/29/2023 - 12/5/2023 | 56.02% |
Ocular Therapeutix (OCUL) | 11/29/2023 - 12/5/2023 | 53.65% |
Millennium Group International Holdings Limited Ordinary Shares (MGIH) | 11/29/2023 - 12/5/2023 | 53.54% |
Elite Education Group International (EEIQ) | 11/29/2023 - 12/5/2023 | 52.33% |
Viking Therapeutics (VKTX) | 11/29/2023 - 12/5/2023 | 47.87% |